Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-K
Source: 0001640334-25-001300
Chunk: 444

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-K
Item: Item 7A
Chunk 444
---
 Incentive Plan(3)31.1Certification of Chief Executive and Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32.1Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer.101.INSXBRL Instance Document101.SCHXBRL Taxonomy Schema Document101.CALXBRL Taxonomy Calculation Document101.DEFXBRL Taxonomy Linkbase Document101.LABXBRL Taxonomy Label Linkbase Document101.PREXBRL Taxonomy Presentation Linkbase Document

______________ 

(1)Filed as an exhibit to the Company’s report on Form 8-K, which was filed with the SEC on February 1, 2017 and incorporated herein by reference.(2)Filed as an exhibit to the Company’s annual report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on July 18, 2025 and incorporated herein by reference.(3)Filed as an exhibit to the Company’s report on Form 8-K, which was filed with the SEC on August 13, 2020 and incorporated herein by reference..

Item 16. FORM 10-K SUMMARY

Not applicable

 28Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ACRO BIOMEDICAL CO., LTD. Date: July 24, 2025By:/s/ Pao-Chi Chu Name:Pao-Chi Chu Title:Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. 

SignatureTitleDate/s/ Pao-Chi ChuDirector, chief executive officer and July 24, 2025Pao-Chi Chuchief financial officer (principal executive, financial and accounting officer)

 29Table of Contents

ACRO BIOMEDICAL CO., LTD.

Index to Financial Statements

 Page Reports of Independent Registered Public Accounting Firms (PCAOB ID 2851) F-2 Balance Sheets at December 31, 2024 and 2023 F-3 Statements of Operations for the years ended December 31, 2024 and 202